Core Viewpoint - Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) by 6,100 shares on November 12, 2025, marking a continued trend of net reductions over recent trading days [1] Group 1: Shareholding Changes - In the last 5 trading days, southbound funds have reduced their holdings for 5 days, with a total net reduction of 40,200 shares [1] - Over the last 20 trading days, there has been a total net reduction of 332,500 shares, with reductions occurring on all 20 days [1] - As of November 12, 2025, southbound funds hold 6,052,800 shares of Gaoshi Medical, representing 4.08% of the company's total issued ordinary shares [1] Group 2: Company Overview - Gaoshi Medical Technology Co., Ltd. primarily engages in ophthalmic medical business, operating through four segments: self-owned products, distribution, technical services, and others [2] - The self-owned products segment develops and manufactures surgical equipment, related software, intraocular lenses, and diagnostic and treatment equipment for eye diseases [2] - The distribution segment sells branded ophthalmic medical devices and consumables, while the technical services segment provides warranty, maintenance, and after-sales services [2] - The company's products are widely used in the examination, treatment, and correction of various ophthalmic sub-specialties, including fundus diseases, cataracts, glaucoma, refraction, and pediatric ophthalmology [2]

Core Viewpoint - Southbound funds have reduced their holdings in Gaoshi Medical (02407.HK) significantly over the past trading days, indicating a potential shift in investor sentiment towards the company [1]. Group 1: Shareholding Changes - On October 14, southbound funds reduced their holdings by 16,300 shares, marking a decrease of 0.25% [2]. - Over the last five trading days, there has been a cumulative net reduction of 80,500 shares, with reductions occurring on all five days [1][2]. - In the last twenty trading days, the total net reduction reached 761,000 shares, with reductions on all twenty days [1]. Group 2: Current Holdings - As of the latest data, southbound funds hold 6,385,300 shares of Gaoshi Medical, which represents 4.31% of the company's total issued ordinary shares [1][2]. Group 3: Company Overview - Gaoshi Medical Technology Co., Ltd. primarily engages in ophthalmic medical services and operates four divisions: self-owned products, distribution, technical services, and others [2]. - The company's products are widely used in various ophthalmic sub-specialties, including fundus diseases, cataracts, glaucoma, refraction, and pediatric ophthalmology [2].